The subsequent MMP‐2‐triggered release of aPD‐L1 reversed tumor‐induced immunosuppression by blocking the PD‐L1/PD‐1 axis, further amplifying T cell‐mediated antitumor responses. The gene discussed is CD274; the disease is neoplasm.